Kalra J, Cortes E, Chen S, Krumholz B, Rovinsky J J, Molho L, Seltzer V, Papantoniou P, Lee J Y
J Clin Oncol. 1985 Jul;3(7):917-24. doi: 10.1200/JCO.1985.3.7.917.
Fifteen patients with advanced or recurrent squamous-cell carcinoma of the cervix, vulva, vagina, and urethra were treated with simultaneous combination chemotherapy (5-fluorouracil infusion and mitomycin C) and radiotherapy (3,000 rad for a period of three weeks). Three to four weeks after completion of radiotherapy, 13 of 15 patients achieved partial or complete tumor shrinkage. Nine of 15 patients are alive, eight of whom (at a median follow-up time of 24 months) have no evidence of disease. The longest survival time was 45 + months. There was minimal toxicity associated with this therapy. The results of this pilot study suggest that the simultaneous administration of radiation and chemotherapy is an effective method of treatment of advanced female genital tract carcinoma.
15例晚期或复发性宫颈、外阴、阴道和尿道鳞状细胞癌患者接受了同步联合化疗(5-氟尿嘧啶输注和丝裂霉素C)和放疗(3000拉德,为期三周)。放疗完成后三至四周,15例患者中有13例肿瘤部分或完全缩小。15例患者中有9例存活,其中8例(中位随访时间为24个月)无疾病证据。最长生存时间为45 +个月。该治疗相关毒性极小。这项初步研究结果表明,放疗和化疗同步进行是治疗晚期女性生殖道癌的有效方法。